Prognosis
Pfizer Starts U.S. Trials of Experimental Covid-19 Vaccine
- Pfizer and partner BioNTech aim for emergency use by fall
- Trials being conducted at NYU, University of Maryland
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
Pfizer Inc. has administered the first U.S. patients with its experimental vaccines to fight the disease caused by the novel coronavirus, part of a bid to shave years off of the typical time it takes to develop a new inoculation.